ADAR1 Capital Management, LLC 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 7:47 pm Purchase | 2025-06-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | ADAR1 Capital Management, LLC | 365,179 9.900% | 50,076 (+15.89%) | Filing |
| 2024-11-14 4:45 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | ADAR1 Capital Management, LLC | 315,103 9.990% | 315,103 (New Position) | Filing |